期刊文献+

BE血凝仪抗干扰能力评价与处理

Evaluation on the Ability of Anti-interference of BE Blood Coagulation Analyzer
下载PDF
导出
摘要 目的探讨BE血凝仪对溶血、脂肪乳、黄疸的抗干扰能力和解决方法。方法制备正常新鲜混合血浆并重复测定凝血酶原时间(PT)和部分凝血活酶时间(APTT);在正常新鲜混合血浆中加入不同浓度溶血、脂肪乳和黄疸干扰物并重复测定其PT和APTT,取均值计算干扰物影响度。结果当添加干扰物脂肪乳>5%时,仪器不能给出PT结果并报警。此外,不同浓度溶血和黄疸干扰物对PT、APTT影响度<±15%,未超过美国CLIA′88规定的允许偏差度。结论 BE血凝仪具有对溶血、黄疸的抗干扰能力,对重度脂血的抗干扰能力有限,重度脂血标本可采用非光学法血凝仪进行复查。 Objective To investigate the anti-interference ability of BE blood coagulation analyzer for hemolysis, lipid milk, jaundice and the solution. Methods Fresh plasma of healthy person were pooled,plasma prothrombin time (PT) and activated partial thromboplastin time (APTT) were measured repeatedly. The disruptors of hemolysis, fat milk and jaundice at different concentrations were added in the normal mixed fresh plasma. The average interference effects were calculated with the repeat measurement results of PT and APTT. Results When the final concentration of fat milk added was 〉5% ,the BE analyzer alarmed and PT results couldn't be given. Besides, the interference effect of different concentration of hemolysis and jaundice for PT and APTT were 〈 15%. It was lower than allowable deviation given by CLIA'88. Conclusions BE blood coagulation analyzer has anti interference ability for hemolysis and jaundice. The anti-in- terference ability for severe fat blood is limited. Coagulation analyzer with non optical method can be used for review.
作者 饶绘 臧莉
出处 《临床输血与检验》 CAS 2013年第4期340-342,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 血凝仪 抗干扰能力 Blood coagulation analyzer Anti-interference ability
  • 相关文献

参考文献4

  • 1National Committee for Clinical Laboratory Standards. One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test : Approved Guideline. NCCLSDocumentH47-A (ISBN1-56238-301- 9 ) [S]. Wayne, PA : NCCLS, 1996.
  • 2陆学军,张将.ACL TOP全自动血凝仪抗干扰能力评价[J].中国医疗设备,2011,26(8):96-100. 被引量:6
  • 3National Committee for Clinical Laboratory Standards.Interference Testing in Clinical Chemistry l Approved Guideline. NCCLS document EPT-A [-ISBN 1-56238- 480-51. NCCLS. 940 West Valley Road, Suite 1400 [S]. Wayne, Pennsylvania : 19087-1898,USA, 2002.
  • 4闻平,杨义侠,陈蕾,万瑛.Throm bolyzer Compact-X全自动血凝仪的性能评价[J].临床输血与检验,2003,5(4):255-256. 被引量:1

二级参考文献36

  • 1郑卫东,范小斌,唐红艳.STA-R全自动血凝仪性能评价[J].实用医学杂志,2005,21(5):533-535. 被引量:20
  • 2王春新,谢国强.ACL200血凝分析仪的应用评价[J].国外医学(临床生物化学与检验学分册),2005,26(3):189-189. 被引量:2
  • 3唐宁,曹文静,夏汛生,张碧玉.ACL TOP全自动血凝分析系统的性能评价[J].医疗设备信息,2007,22(2):48-51. 被引量:17
  • 4马永能,张鹏,潘淑,刘慧玲.ACL 8000型凝血分析仪的抗干扰功能[J].现代检验医学杂志,2007,22(4):46-48. 被引量:1
  • 5Mohammed A, Mehnabani PA, Coombs R, et al. The MDA-180 coagulation analyzer :a laboratory evaluation[J]. Pathology, 1997, 29 (2) : 176-183.
  • 6National committe for clinical laboratory standard.C24-A internal quality control testing principles and definition:Approved Guideline[S]. NCCLS, 1991.
  • 7H30-A procedure for determination of fibrinogem in plasma :Approved Guideline[S]. NCCLS, 1999.
  • 8Eschwege V,,Catillon C,Robert A.Evaluation of the automatedcoagulation analyzer ACL TOP. Annales de BiologieClinique . 2006
  • 9National Committee for Clinical Laboratory Standards.Procedurefor the Determination of Fibrinogen in Plasma;ApprovedGuideline-Second Edition. NCCLS Document H30-A2 . 2001
  • 10Barnes PW,,Eby CS.An evaluation of the performancecharacteristics of the ACL TOP?coagulation system. Clinical Chemistry . 2004

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部